MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling

Androgen deprivation therapy (ADT) is the main therapeutic option for advanced prostate cancer (PCa). After initial regression, most tumors develop into castration-resistant PCa (CRPC). Previously, we found the Mediator complex subunit MED15 to be overexpressed in CRPC and to correlate with clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Offermann, Anne, Vlasic, Ignacija, Syring, Isabella, Vogel, Wenzel, Ruiz, Christian, Zellweger, Tobias, Rentsch, Cyrill A, Hagedorn, Susanne, Behrends, Jochen, Nowak, Michael, Merseburger, Axel, Bubendorf, Lukas, Kirfel, Jutta, Duensing, Stefan, Adler, David, Perner, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352374/
https://www.ncbi.nlm.nih.gov/pubmed/27974704
http://dx.doi.org/10.18632/oncotarget.13860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352374/
https://www.ncbi.nlm.nih.gov/pubmed/27974704
http://dx.doi.org/10.18632/oncotarget.13860

Ejemplares similares